Your browser doesn't support javascript.
loading
More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence.
Pham, James P; Staeger, Ramon; Frew, John W.
Afiliação
  • Pham JP; Department of Dermatology, Liverpool Hospital, Liverpool, New South Wales, Australia; Laboratory of Translational Cutaneous Medicine, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia; School of Clinical Medicine, University of New South Wales Medicine and Health, Sydney, New South Wales, Australia. Electronic address: james.pham@unsw.edu.au.
  • Staeger R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine and Health, University of Zurich, Zurich, Switzerland.
  • Frew JW; Department of Dermatology, Liverpool Hospital, Liverpool, New South Wales, Australia; Laboratory of Translational Cutaneous Medicine, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia; School of Clinical Medicine, University of New South Wales Medicine and Health, Sydney, New South Wales, Australia.
J Am Acad Dermatol ; 90(5): e171-e173, 2024 May.
Article em En | MEDLINE | ID: mdl-38185252
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Histiocitoma Fibroso Maligno Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Histiocitoma Fibroso Maligno Idioma: En Ano de publicação: 2024 Tipo de documento: Article